PHARMACOTHERAPEUTICS FOR ADVANCED
PRACTICE NURSE PRESCRIBERS
CERTIFICATION EVALUATION 2026 BUNDLED
MATERIAL ANSWERS
◉ Progestins. Answer: Bind to progesterone receptors, regulating
reproductive functions.
◉ Hormone Replacement Therapy (HRT). Answer: Used in
menopausal women for relief of vasomotor symptoms, prevention of
osteoporosis, and management of urogenital atrophy.
◉ Combined Oral Contraceptives (COCs). Answer: Contain both
estrogen and progestin, inhibit ovulation, alter cervical mucus, and
modify the endometrial lining to prevent pregnancy.
◉ Androgens. Answer: Bind to androgen receptors, promoting the
development and maintenance of male characteristics.
◉ Male Hypogonadism. Answer: Indication for androgen therapy.
◉ Copper IUDs. Answer: Non-hormonal intrauterine devices that
create an inhospitable environment for sperm.
,◉ Levonorgestrel-releasing IUDs. Answer: Hormonal intrauterine
devices that may inhibit implantation.
◉ Polycystic Ovary Syndrome (PCOS). Answer: A reproductive
disorder that can be managed with pharmacologic interventions like
COCs and Metformin.
◉ Metformin. Answer: Improves insulin sensitivity and may aid in
ovulation for PCOS.
◉ Anti-Androgens. Answer: Medications like spironolactone used to
address hirsutism and acne.
◉ Endometriosis. Answer: A reproductive disorder treated with
NSAIDs, hormonal therapies, and surgical interventions.
◉ NSAIDs. Answer: First-line treatment for pain management in
endometriosis.
◉ Selective Serotonin Reuptake Inhibitors (SSRIs). Answer: Non-
hormonal alternatives for managing menopausal symptoms.
,◉ Gabapentin. Answer: Non-hormonal alternative for managing
menopausal symptoms.
◉ Thromboembolic Events. Answer: Potential adverse effect of
hormonal therapies.
◉ Uterine Perforation. Answer: A rare risk associated with IUDs.
◉ Irregular Bleeding. Answer: An adverse effect of progestin-only
contraceptive methods.
◉ Weight Gain. Answer: An adverse effect associated with progestin-
only contraceptive methods.
◉ Mood Changes. Answer: An adverse effect that can occur with
hormonal therapies.
◉ Breast Cancer Risk. Answer: Increased risk associated with
combined hormone replacement therapy.
◉ Cardiovascular Events. Answer: Potential risk associated with
hormone replacement therapy.
, ◉ Stroke. Answer: A potential risk associated with hormone
replacement therapy.
◉ Counseling Points. Answer: Discuss potential side effects and
emphasize adherence to prescribed regimens.
◉ Monitoring. Answer: Regular follow-ups to assess efficacy and
tolerability of therapies.
◉ Vasomotor Symptoms. Answer: Symptoms like hot flashes that
HRT aims to relieve.
◉ Menstrual Disorders. Answer: Conditions that can be managed
with hormonal therapies.
◉ Contraceptive Benefits. Answer: Regulation of menstrual cycles
and reduction in menstrual cramps.
◉ Contraindications for COCs. Answer: History of thromboembolic
disorders, uncontrolled hypertension, and migraines with aura.
◉ Progestin-Only Methods. Answer: Include pills, injectables (e.g.,
Depo-Provera), and implants (e.g., Nexplanon).
PRACTICE NURSE PRESCRIBERS
CERTIFICATION EVALUATION 2026 BUNDLED
MATERIAL ANSWERS
◉ Progestins. Answer: Bind to progesterone receptors, regulating
reproductive functions.
◉ Hormone Replacement Therapy (HRT). Answer: Used in
menopausal women for relief of vasomotor symptoms, prevention of
osteoporosis, and management of urogenital atrophy.
◉ Combined Oral Contraceptives (COCs). Answer: Contain both
estrogen and progestin, inhibit ovulation, alter cervical mucus, and
modify the endometrial lining to prevent pregnancy.
◉ Androgens. Answer: Bind to androgen receptors, promoting the
development and maintenance of male characteristics.
◉ Male Hypogonadism. Answer: Indication for androgen therapy.
◉ Copper IUDs. Answer: Non-hormonal intrauterine devices that
create an inhospitable environment for sperm.
,◉ Levonorgestrel-releasing IUDs. Answer: Hormonal intrauterine
devices that may inhibit implantation.
◉ Polycystic Ovary Syndrome (PCOS). Answer: A reproductive
disorder that can be managed with pharmacologic interventions like
COCs and Metformin.
◉ Metformin. Answer: Improves insulin sensitivity and may aid in
ovulation for PCOS.
◉ Anti-Androgens. Answer: Medications like spironolactone used to
address hirsutism and acne.
◉ Endometriosis. Answer: A reproductive disorder treated with
NSAIDs, hormonal therapies, and surgical interventions.
◉ NSAIDs. Answer: First-line treatment for pain management in
endometriosis.
◉ Selective Serotonin Reuptake Inhibitors (SSRIs). Answer: Non-
hormonal alternatives for managing menopausal symptoms.
,◉ Gabapentin. Answer: Non-hormonal alternative for managing
menopausal symptoms.
◉ Thromboembolic Events. Answer: Potential adverse effect of
hormonal therapies.
◉ Uterine Perforation. Answer: A rare risk associated with IUDs.
◉ Irregular Bleeding. Answer: An adverse effect of progestin-only
contraceptive methods.
◉ Weight Gain. Answer: An adverse effect associated with progestin-
only contraceptive methods.
◉ Mood Changes. Answer: An adverse effect that can occur with
hormonal therapies.
◉ Breast Cancer Risk. Answer: Increased risk associated with
combined hormone replacement therapy.
◉ Cardiovascular Events. Answer: Potential risk associated with
hormone replacement therapy.
, ◉ Stroke. Answer: A potential risk associated with hormone
replacement therapy.
◉ Counseling Points. Answer: Discuss potential side effects and
emphasize adherence to prescribed regimens.
◉ Monitoring. Answer: Regular follow-ups to assess efficacy and
tolerability of therapies.
◉ Vasomotor Symptoms. Answer: Symptoms like hot flashes that
HRT aims to relieve.
◉ Menstrual Disorders. Answer: Conditions that can be managed
with hormonal therapies.
◉ Contraceptive Benefits. Answer: Regulation of menstrual cycles
and reduction in menstrual cramps.
◉ Contraindications for COCs. Answer: History of thromboembolic
disorders, uncontrolled hypertension, and migraines with aura.
◉ Progestin-Only Methods. Answer: Include pills, injectables (e.g.,
Depo-Provera), and implants (e.g., Nexplanon).
